The PM exhorted that the country needs to institutionalise the best practices learnt during the last one and a half years. PM Modi interacted with the domestic vaccine manufacturers at Lok Kalyan Marg. Prime Minister Narendra Modi on Saturday praised efforts of Indian vaccine manufacturers, which, he said, resulted in the country crossing the milestone … Read more
SII also had the first-mover advantage with CEO Adar Poonawalla getting into multiple deals with potential Covid-19 vaccine candidates and different partners. India’s total number of administered vaccine doses is set to cross the 100-crore milestone in the next few days. The country has already vaccinated 70% of its eligible citizens with the first dose … Read more
The submission to WHO was based on the companies’ previous regulatory submission to the Drugs Controller General of India (DCGI). Biotech company Novavax and vaccine maker Serum Institute of India (SII) have applied to the World Health Organisation (WHO) for an emergency use listing (EUL) for the Novavax Covid-19 vaccine. Novavax and SII made regulatory … Read more
SII has got exclusive rights for the vaccine in India and non-exclusive rights during the pandemic period in all countries excluding upper-middle/high-income countries. Serum Institute of India (SII) and US biotechnology company Novavax on Friday applied for emergency use authorisation to the Drugs Controller General of India to launch Covid-19 vaccine Covovax in India. Novavax … Read more
Serum Institute of India has said that it has not exported doses of the vaccine at the cost of Indians. In a statement, the company has said that in January 2021, the company had a large stockpile of vaccine doses. The vaccination drive had started successfully and the number of daily cases being recorded were … Read more
NEW DELHI: A Chinese state-backed hacking group has in recent weeks targeted the IT systems of two Indian vaccine makers whose coronavirus shots are being used in the country’s immunisation campaign, cyber intelligence firm Cyfirma told Reuters. Rivals China and India have both sold or gifted Covid-19 shots to many countries. India produces more than … Read more
The first phase of the vaccination, covering three crore healthcare and frontline workers, begins on January 16 with orders shared between SII and Bharat Biotech. Serum Institute of India (SII) has received a purchase order from the Government of India to supply 1.1 crore doses of its Covid-19 vaccine, sources in the company said. Serum … Read more
These and several other questions continue to emerge as long as there is no clarity from the government on its plans on procurement and distribution. Five days before the actual rollout of the vaccination programme to cover healthcare professionals, frontline workers and the vulnerable elderly, order for the procurement of the vaccine has finally been … Read more
Coronavirus Covid 19 vaccine emergency use authorisation: (Reuters/Representational Photo) Covid-19 vaccine emergency use authorisation: The Ministry of Health and Family Welfare informed on Wednesday that the Subject Expert Committee (SEC) in Central Drugs Standard Control Organisation (CDSCO) held a meeting to consider the Emergency Use Authorisation (EUA) request of Pfizer, Serum Institute of India (SII) … Read more
A Serum team was in Delhi to meet the officials and subsequently announced that they were halting the trials. Pune-based vaccine maker Serum Institute of India on Thursday halted the ongoing clinical trials of the Covid-19 vaccine in the country. “We are reviewing the situation and pausing India trials till AstraZeneca restarts trials,” a statement issued … Read more